,^2_<B=>M]<,;'YN[|L'##*
SYSTEM PROCESSING...
,^2_<B=>M]<,;'YN[|L'##*
SYSTEM PROCESSING...
Posted: 2025-04-22 18:01:58 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-22 18:02:19 UTC
Verified By
Rollup News
Researchers have engineered human microglia to act as living delivery systems, releasing therapeutic proteins in response to brain pathology, offering a new strategy for treating Alzheimer’s disease. This approach has shown promise in mouse models by reducing plaque buildup, inflammation, and neuronal damage.
Targeted Delivery: Engineered microglia only activate in response to amyloid plaques.
Therapeutic Impact: Reduced neuroinflammation and preserved neuronal health in mice.
Broad Potential: Adaptable platform for treating Alzheimer’s, brain cancer, and MS.